Crossmark

Early use of neutral Protamine Hagedorn (NPH) insulin in the management of diabetic ketoacidosis: an open-label randomized controlled trial in a resource-limited setting

Crossref DOI link: https://doi.org/10.1186/s13104-025-07508-5

Published Online: 2025-11-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baby, Naveen

Wyawahare, Mukta

Naik, Dukhabandhu

Ramasamy, Nishaant
Funding

Funding for this research was provided by:

Jawaharlal Institute Of Postgraduate Medical Education and Research (IMRF/JULY-SEPT 2022-23/Proposal no 3/)
License Information

Text and Data Mining valid from 2025-11-07

Version of Record valid from 2025-11-07
More Information

Article History

Received: 25 June 2024

Accepted: 21 September 2025

First Online: 7 November 2025

Declarations

:

: This study was approved by the Institute Ethics Committee at Jawaharlal Institute of Postgraduate Medical Education and Research (Ref No JIP/IEC/2021/078). Written informed consent was obtained from the participants.

: Written informed consent was obtained from the study participants.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below